Browse studies

Find your next paid study

9 recruiting studies matching your filters

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)

Researchers are looking for new ways to treat radiographic axial spondyloarthritis (r-axSpA). R-axSpA is a type of arthritis that causes pain, stiffness, and i…

Radiographic Axial Spondyloarthritis

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT07133633

Phase 4

A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis (UP-SPOUT)

A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients with Active Psoriatic Art…

Psoriatic ArthritisSpondyloarthritis, Axial

Estimated

~$25 – $1,400

Actual pay is set by the research site.

CARE ARTHRITIS LTD.NCT06454188

Phase 4

A Pragmatic Randomized Pilot Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis

The purpose of this study is to determine the feasibility of conducting a pragmatic trial of IL-17i versus JAKi in adults with axial spondyloarthritis (axSpA) …

Axial Spondyloarthritis (AxSpA)

Estimated

~$25 – $1,000

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT07770646

Phase 1

A Multicenter Open-label, Prospective Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.

Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

UCB Biopharma SRLNCT06888193

Phase 1

An Open-label, Randomized, Parallel-group, Noninferiority Study to Evaluate the Pharmacokinetics of Bimekizumab Administered Intravenously or as a Subcutaneous Injection in Participants With Active Psoriatic Arthritis and/or Active Axial Spondyloarthritis

To demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.

Psoriatic ArthritisAxial Spondyloarthritis

Estimated

~$150 – $4,200

Actual pay is set by the research site.

UCB Biopharma SRLNCT07290036

Observational

Pilot Randomized Controlled Trial of the RENEW Intervention for Axial Spondyloarthritis

The researchers are testing a web-based peer-led program to help manage energy and symptoms in people who have axial spondyloarthritis (axSpA). There are 3 mai…

Axial Spondyloarthritis

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MichiganNCT07836374

GLOBE-SpA - GuseLkumab for Overlap Inflammatory Bowel DiseasE and Spondyloarthritis

This is an observational study of a prospective cohort of guselkumab-initiating Crohn's Disease (CD) and Ulcerative Colitis (UC) patients to identify new or in…

SpondyloarthritisInflammatory Bowel Diseases

Estimated

~$10 – $1,125

Actual pay is set by the research site.

NYU Langone HealthNCT07602517

Observational

Expanding Access to Early Exercise Prescriptions for Underserved Patients With Axial Spondyloarthritis: A Digital Health Approach

The purpose of this study is to find out whether a mobile app called the ExerciseRx app is a practical and helpful way for people with axial spondyloarthritis …

Axial Spondyloarthritis

Estimated

~$10 – $750

Actual pay is set by the research site.

University of WashingtonNCT07642622

Objective Grading of Intraocular Inflammation in Uveitis Using Optical Coherence Tomography

The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiase…

Anterior Uveitis (AU)Birdshot ChorioretinitisBehcet Disease+5 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Oregon Health and Science UniversityNCT07065747